CAS 95311-94-7
:Lucidenic acid A
Description:
Lucidenic acid A, with the CAS number 95311-94-7, is a triterpenoid compound primarily derived from the medicinal mushroom Ganoderma lucidum, commonly known as reishi. This compound is characterized by its complex tetracyclic structure, which contributes to its bioactivity. Lucidenic acid A exhibits a range of pharmacological properties, including anti-inflammatory, antioxidant, and potential anticancer effects, making it of interest in both traditional medicine and modern pharmacology. Its mechanism of action is thought to involve modulation of various signaling pathways, which may enhance immune response and inhibit tumor growth. Additionally, lucidenic acid A has been studied for its effects on metabolic disorders, showcasing its potential in managing conditions like diabetes. The compound is typically isolated through extraction and purification processes, and its stability and solubility can vary based on environmental conditions. Overall, lucidenic acid A represents a significant area of research in natural products chemistry and therapeutic applications.
Formula:C27H38O6
InChI:InChI=1S/C27H38O6/c1-14(7-8-21(32)33)15-11-20(31)27(6)23-16(28)12-18-24(2,3)19(30)9-10-25(18,4)22(23)17(29)13-26(15,27)5/h14-16,18,28H,7-13H2,1-6H3,(H,32,33)/t14-,15-,16+,18+,25+,26-,27+/m1/s1
InChI key:InChIKey=INIPQDKLXQHEAJ-NCQSLMINSA-N
SMILES:C[C@]12C3=C([C@]4(C)[C@@](C[C@@H]3O)(C(C)(C)C(=O)CC4)[H])C(=O)C[C@]1(C)[C@@]([C@@H](CCC(O)=O)C)(CC2=O)[H]
Synonyms:- (+)-Lucidenicacid A
- (5α,7β)-7-Hydroxy-4,4,14-trimethyl-3,11,15-trioxochol-8-en-24-oic acid
- Lucidenic acid A
- Lucideric acid A
- Chol-8-en-24-oic acid, 7-hydroxy-4,4,14-trimethyl-3,11,15-trioxo-, (5α,7β)-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
Lucideric acid A
CAS:<p>Lucideric acid A boosts LPS-induced immune responses in THP-1 cells, modulating JNK/p38 MAPKs.</p>Formula:C27H38O6Purity:99.89%Color and Shape:SolidMolecular weight:458.59Lucidenic acid A
CAS:Controlled Product<p>Lucidenic acid A is a phloroglucinol derivative that has been shown to have anti-angiogenic effects in vitro. It inhibits the growth of human cervical cancer cells by causing cell death and inhibiting the proliferation of hemolytic activity. Lucidenic acid A targets mitochondria and induces apoptosis in hl-60 cells. Lucidenic acid A also has significant cytotoxicity against human tumor cell lines, as well as sporocarp tissue culture. The chemical structure of lucidenic acid A is similar to that of ganoderma lucidum, a type of mushroom with anti-cancer properties. The mechanism by which it exerts its cytotoxic effects is not yet known, but it may be due to denaturation or inhibition of growth factors such as vascular endothelial growth factor (VEGF).</p>Formula:C27H38O6Purity:Min. 95%Color and Shape:White PowderMolecular weight:458.59 g/mol






